The use of data analytics and Artificial Intelligence (AI) techniques to aid the development of new pharmaceutical products is rapidly increasing. Core to the implementation of these approaches is access to relevant, robust analytical data – key to predicting the properties and performance of candidate molecules and drug product formulations. Data analytics can enable the elimination of non-viable drug candidates early in the development cycle and accelerate the progress of viable molecules, reducing the time and cost of getting a new drug product to market.
Although the importance of data is well understood, the pressure to reduce product development times and streamline QC often means that pharmaceutical companies cannot develop the deep understanding required to effectively select, deploy and maintain appropriate analytical technologies. These companies are increasingly seeking active partnerships with analytical instrumentation suppliers and contract research organizations to help them apply advanced measurement techniques to ensure the delivery of meaningful, robust data which can be trusted to inform decisions.
In this webinar, we will present a new joint venture between Malvern Panalytical and Concept Life Sciences, created to address the challenges of accessing meaningful data to aid pharmaceutical, agrochemical and food product development. This partnership will operate under a single client-facing delivery platform within the Spectris group. Malvern Panalytical has a long and trusted history in the development of material characterization techniques to support pharmaceutical product development and quality control. Concept Life Sciences has in-depth knowledge of the requirements for pharmaceutical product development and the regulatory frameworks which ensure data integrity. Together, we are building a unique service which will enable us to partner with our customers to release the true value of advanced analytical data.
Please join us on March 31st and be among the first to hear more about this exciting new partnership!
Date:March 31 2020
Time:10:30 – 11:30 am (GMT-05:00) Bogotá, Colombia
Paul Kippax Ph.D. – Pharma Sector Director – Malvern Panalytical
Ben Cliff Ph.D. – VP Concept Life Sciences
- Who should attend?
– Researchers in the pharmaceutical, agro-chemical and food industries who are involved in the selection of appropriate analytical techniques and methods
– R+D and manufacturing leaders responsible for appropriate analytics selection
– Scientists engaged in method development for new materials or in supporting root cause analysis investigations in support of product manufacturing
– Analytical scientists and laboratory managers engaged in supporting technique selection for bio-equivalence studies and downstream quality control
- What will you learn?
– Why analytical data is a key enabler in rapid, effective product development
– How Malvern Panalytical and Concept Life Sciences are now working together to partner with our customers to develop, deploy and support the use of advanced analytical techniques
– What services Malvern Panalytical and Concept Life Sciences can offer and how you can benefit from these
Registro para el evento aquí: